Sanofi transferred drug production and packaging for 22 medicine brands to Romanian facility
French pharmaceutical group Sanofi transferred the packaging and production operations for 22 drug brands to Zentiva plant in Romania, while 30 other products run various transfer stages, the company announced.
Within the 22 drug products transferred in 2013, 15 drugs are completely produced while for other seven, the company runs the packaging process. In 2013, the producer attained exports for 25 drug products, representing 133 pharmaceutical features in countries such as: France, Germany, Great Britain, Italy, Bulgaria, Czech Republic, Slovakia and Hungary.
The exports achieved by Zentiva facility attained 19 percent within the overall sales in 2013, compared to only 7 percent in 2012. The largest exports have been managed for Germany with 5.3 million lei, France with 26.2 million, Italy with 7.8 million, besides Poland, Portugal and Czech Republic. Out of 112 drug products for humans, including 107 medicine products and 5 natural supplement products, 77 percent are produced in Romania and 23 percent are produced in Sanofi Zentiva facilities outside the country.
In 2013, the company announced it invested EUR 2.9 million for new production equipments and upgraded to existing ones. For 2014, the company plans to increase by 18.6 percent the net profit, to reach EUR 10.7 million (47.8 million lei). In 2013, Zentiva announced a profit worth EUR 9.1 million (40.3 million lei), 25 percent up compared to 2012. Also, the company turnover reached EUR 65.8 million (291 million) in 2013, 20 percent more compared to previous year. According to latest data, Sanofi-Aventis owns 81.6 percent from Zentiva stock of shares.
In 2013, Zentiva numbered 483 employees, 67 down comoared to 2012. The French group Sanofi-Aventis is second largest on the Romanian market, with 7 percent market share and sales worth 827.5 million lei. The top medicine producer in Romania is Roche Group, according to a Cegedim ranking.